Baltimore, MD, United States of America

Daniel Mulreany

This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2015-2016.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Mulreany

Introduction

Daniel Mulreany is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of wound healing through his innovative patents. With a total of two patents to his name, Mulreany's work focuses on biocompatible cellulose hydrogel membranes.

Latest Patents

Mulreany's latest patents include compositions for wound healing that utilize biocompatible hydrogel membranes. These membranes possess several advantageous properties, such as high water content, high transparency, high permeability, high biocompatibility, high tensile strength, and an optimal thickness. The invention outlines methods for treating wounds by applying these hydrogel membranes to affected areas, providing effective solutions for individuals in need of wound care.

Career Highlights

Daniel Mulreany is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Mulreany collaborates with esteemed colleagues, including Morgana M Trexler and Jenna L Graham. Their combined expertise contributes to the development of cutting-edge solutions in the field of wound healing.

Conclusion

Daniel Mulreany's contributions to wound healing technology exemplify the importance of innovation in medical science. His patents reflect a commitment to improving patient outcomes through advanced materials and methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…